Focus:

Cancer Channel Featured Story TOP

Add to Favorites Subscribe Share
fbshare-Cancer Channel Featured Story TOP

Showing results

110 of 104
Embargo will expire:
24-Oct-2019 11:00 AM EDT
Released to reporters:
22-Oct-2019 12:00 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Oct-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Creatine powers T cells’ fight against cancer

Article ID: 721010

Creatine powers T cells’ fight against cancer

UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research

The study, conducted in mice, is the first to show that creatine uptake is critical to the anti-tumor activities of killer T cells, the foot soldiers of the immune system.

Released:
18-Oct-2019 12:05 PM EDT
image.png

Article ID: 720832

Expert Panel: Cancer Treatment Plans Should Include Tailored Exercise Prescriptions

American College of Sports Medicine (ACSM)

New guidance from exercise oncology experts recommend systematic use of an “exercise prescription” by health care workers and fitness professionals in designing and delivering exercise programs that aim to lower the risk of developing certain cancers and best meet the needs, preferences and abilities of people with cancer. 17 organizations reviewed the latest scientific evidence and offer recommendations about the benefits of exercise for prevention, treatment, recovery and improved survival.

Released:
16-Oct-2019 8:50 AM EDT
Newswise: Following NCCN Guidelines for Metastatic Breast Cancer Results in Lower Costs for Patients, According to New Study
  • Embargo expired:
    10-Oct-2019 9:00 AM EDT

Article ID: 720481

Following NCCN Guidelines for Metastatic Breast Cancer Results in Lower Costs for Patients, According to New Study

National Comprehensive Cancer Network® (NCCN®)

Patients pay less out-of-pocket for metastatic breast cancer (MBC) treatment that aligns with recommendations from NCCN Guidelines, according to a new study from the O’Neal Comprehensive Cancer Center at University of Alabama at Birmingham (UAB), published in the October 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network.

Released:
9-Oct-2019 4:05 PM EDT
Horizontal-CHLA-Logo.png

Article ID: 719042

First Positive Results in 45 Years: Rhabdomyosarcoma Randomized Clinical Trial Led by Children’s Hospital Los Angeles

Children's Hospital Los Angeles

A randomized clinical trial led at Children's Hospital Los Angeles by Leo Mascarenhas, MD, MS, showed first positive results in rhabdomyosarcoma since 1974.

Released:
17-Sep-2019 8:00 AM EDT
Newswise: Failed Cancer Drug Looks Promising For Scleroderma And Other Fibrotic Conditions

Article ID: 718812

Failed Cancer Drug Looks Promising For Scleroderma And Other Fibrotic Conditions

Johns Hopkins Medicine

Sixteen years ago, a research group at Mayo Medical School published results showing that a protein called TRAIL can kill cells that cause liver fibrosis but no one seemed to follow up on these findings. Now, researchers at Johns Hopkins Medicine have improved on this protein and shown that it selectively kills cells that cause the hardening of skin associated with scleroderma, effectively reversing the condition in mice genetically engineered to mimic the disease. A report on these results was published earlier this year in Nature Communications.

Released:
12-Sep-2019 9:00 AM EDT
Newswise: 2019 Gynecologic Cancer Survivorship Conference: Thriving Through Education and Connection

Article ID: 718431

2019 Gynecologic Cancer Survivorship Conference: Thriving Through Education and Connection

Johns Hopkins Medicine

A premier educational event sponsored by the Johns Hopkins Kelly Gynecologic Oncology Service and the Division of Gynecologic Oncology at Sibley Memorial Hospital, this one-day conference gathers more than 25 experts to provide cancer survivors and their caregivers

Released:
5-Sep-2019 9:00 AM EDT

Article ID: 718182

Birmingham Woman Meets Philadelphia Man Who Saved Her Life Through Bone Marrow Donation

Children's of Alabama

Jada Lucas, a 22-year-old bone marrow recipient from Birmingham, met the bone marrow donor who helped save her life — Jerome Lewis of Philadelphia, Penn. — at donor registry event at Children's of Alabama.

Released:
28-Aug-2019 3:05 PM EDT
Newswise: Will Disposable Colonoscopy Devices Replace Reusables?

Article ID: 717929

Will Disposable Colonoscopy Devices Replace Reusables?

Johns Hopkins Medicine

As a disposable version of the instrument used in one of the most common medical procedures in the United States inches closer to widespread availability, a team of Johns Hopkins data researchers is studying the economic and safety implications associated with the devices used to perform colonoscopies.

Released:
26-Aug-2019 9:00 AM EDT
  • Embargo expired:
    21-Aug-2019 5:00 PM EDT

Article ID: 717580

Unprecedented Therapy Found Effective for Blood Cancer Patients With No Treatment Options

Mount Sinai Health System

Mount Sinai researchers have found a new type of therapy to be effective for patients with a particular type of bone marrow cancer that is resistant to several standard therapies, according to results of a clinical trial published in The New England Journal of Medicine in August.

Released:
16-Aug-2019 11:00 AM EDT

Showing results

110 of 104

Chat now!